Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive

被引:124
作者
Selleng, S. [1 ]
Malowsky, B. [2 ]
Strobel, U. [1 ]
Wessel, A. [1 ]
Ittermann, T. [3 ]
Wollert, H. -G. [2 ]
Warkentin, T. E. [4 ,5 ]
Greinacher, A. [1 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany
[2] Herz & Diabet Zentrum Mecklenburg Vorpommern, Klin Herz Thorax & Gefasschirurg, Karlsburg, Germany
[3] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17475 Greifswald, Germany
[4] McMaster Univ, Michael G DeGroote Sch Med, Dept Pathol & Mol Med, Hamilton, ON, Canada
[5] McMaster Univ, Michael G DeGroote Sch Med, Dept Med, Hamilton, ON, Canada
关键词
cardiopulmonary bypass; diagnosis; heparin-induced thrombocytopenia; platelets; CARDIOPULMONARY BYPASS; UNFRACTIONATED HEPARIN; RISK; THROMBOSIS;
D O I
10.1111/j.1538-7836.2009.03626.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The high frequency of thrombocytopenia in post-cardiac surgery patients makes it challenging to diagnose heparin-induced thrombocytopenia (HIT). Two platelet count profiles are reported as indicating possible HIT in these patients: profile 1 describes a platelet count fall that begins between postoperative days 5 and 10, whereas profile 2 denotes early-onset thrombocytopenia that persists beyond day 5. Objectives: To examine how these platelet count profiles correlate with antibody status and HIT post-cardiac surgery. Methods: We prospectively screened 581 cardiac surgery patients for heparin-dependent antibodies by platelet factor 4 (PF4)-heparin immunoassay and platelet-activation test, and performed daily platelet counts (until day 10) with 30-day follow-up. Results: All three patients with platelet count profile 1 tested positive for platelet-activating anti-PF4-heparin IgG antibodies [odds ratio (OR) 521.7, 95% confidence interval (CI) 3.9-34 000, P = 0.002], and were judged to have HIT. In contrast, none of 25 patients with early-onset and persisting thrombocytopenia (profile 2) was judged to have HIT, including five patients testing positive for platelet-activating anti-PF4-heparin IgG antibodies. In these patients, the frequency of heparin-dependent antibodies did not differ from that in non-thrombocytopenic controls, either for anti-PF4-heparin IgG (OR 1.7, 95% CI 0.7-4.1, P = 0.31) or for platelet-activating antibodies (OR 1.9, 95% CI 0.6-5.7, P = 0.20). Multivariate analysis revealed that type of cardiac surgery, but not HIT antibody status, predicted early-onset and persisting thrombocytopenia. Together, these findings show that HIT was uncommon in this study population [overall frequency, 3/581 (0.5%), 95% CI 0.1-1.5%]. Conclusions: Thrombocytopenia that begins between 5 and 10 days post-cardiac surgery is highly predictive for HIT. In contrast, early-onset and persisting thrombocytopenia is usually caused by non-HIT factors with coinciding heparin-dependent antibody seroconversion.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 19 条
[1]  
Bauer TL, 1997, CIRCULATION, V95, P1242
[2]  
Greinacher A., 2007, HEPARIN INDUCED THRO, V4, P283
[3]   Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia [J].
Juhl, D ;
Eichler, P ;
Lubenow, N ;
Strobel, U ;
Wessel, A ;
Greinacher, A .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) :420-426
[4]   Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings [J].
Lo, GK ;
Juhl, D ;
Warkentin, TE ;
Sigouin, CS ;
Eichler, P ;
Greinacher, A .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :759-765
[5]  
LOUET AL, 2004, J THROMB HAEMOST, V2, P1882
[6]   Heparin/PF4 antibodies formation after heparin treatment: Temporal aspects and long-term follow-up [J].
Mattioli, Anna Vittoria ;
Bonetti, Lorenzo ;
Zennaro, Mauro ;
Ambrosio, Giuseppe ;
Mattioli, Giorgio .
AMERICAN HEART JOURNAL, 2009, 157 (03) :589-595
[7]   Blood product use in cardiac revascularization: Comparison of on- and off-pump techniques [J].
Nader, ND ;
Khadra, WZ ;
Reich, NT ;
Bacon, DR ;
Salerno, TA ;
Panos, AL .
ANNALS OF THORACIC SURGERY, 1999, 68 (05) :1640-1643
[8]   European system for cardiac operative risk evaluation (EuroSCORE) [J].
Nashef, SAM ;
Rogues, F ;
Michel, P ;
Gauducheau, E ;
Lemeshow, S ;
Salamon, R .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 16 (01) :9-13
[9]   Antibodies to platelet factor 4 - Heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin - Clinical implications for heparin-induced thrombocytopenia [J].
Pouplard, C ;
May, MA ;
Iochmann, S ;
Amiral, J ;
Vissac, AM ;
Marchand, M ;
Gruel, Y .
CIRCULATION, 1999, 99 (19) :2530-2536
[10]   Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies [J].
Pouplard, C ;
May, MA ;
Regina, S ;
Marchand, M ;
Fusciardi, J ;
Gruel, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) :837-841